Abstract
Background
Inconsistent results regarding the relationship between interleukin (IL)-6 gene polymorphisms, serum IL-6 levels, and the treatment in obstructive sleep apnea (OSA) have been reported. This meta-analysis assessed the associations between IL-6 gene polymorphisms and OSA susceptibility, IL-6 levels in OSA, and CPAP (continuous positive airway pressure) and T&A (tonsillectomy and adenoidectomy) therapy for IL-6 in OSA.
Methods
Studies regarding IL-6 polymorphisms, serum IL-6 levels, and OSA treatment were identified using PubMed and Embase. The associations between IL-6 gene polymorphisms and OSA risk (estimated by pooling odds ratios (ORs) with 95 % confidence intervals (CIs)) were assessed using an allele model. The pooled standardized mean differences (SMDs) with 95 % CI of IL-6 were estimated using a random-effects model. Meta-regression, sensitivity analysis, and publication bias were also evaluated.
Results
In total, 53 studies were included. In adults, a significant association between -174 G/C and OSA susceptibility was observed (OR = 1.46, 95 % CI = 1.14–1.87) and IL-6 levels were higher in OSA compared to controls (SMD = 1.56, 95 % CI = 1.18–1.95); however, no association was observed for the -572 G/C allele (OR = 1.13, 95 % CI = 0.87–1.47) and OSA susceptibility and there was no significant change in IL-6 in pre- and post-CPAP therapy (SMD = −0.24, 95 % CI = −0.73 to 0.26). In children, IL-6 levels were also higher in OSA (SMD = 1.27, 95 % CI = 0.29–2.26) and T&A treatment significantly decreased them (SMD = −0.97, 95 % CI = −1.72 to −0.22).
Conclusions
This meta-analysis indicates that the IL-6 gene polymorphism -174 G/C, and not -572 G/C, is associated with adult OSA risk. Although IL-6 levels increased in OSA, CPAP did not significantly suppress them in adults with OSA. In children with OSA, IL-6 levels also increased and T&A therapy significantly decreased them.
Similar content being viewed by others
References
Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM (2013) Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 177:1006–1014
Bradley TD, Floras JS (2009) Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373:82–93
Butt M, Dwivedi G, Khair O, Lip GY (2010) Obstructive sleep apnea and cardiovascular disease. Int J Cardiol 139:7–16
Friberg D, Sundquist J, Li X, Hemminki K, Sundquist K (2009) Sibling risk of pediatric obstructive sleep apnea syndrome and adenotonsillar hypertrophy. Sleep 32:1077–1083
Larkin EK, Patel SR, Goodloe RJ, Li Y, Zhu X, Gray-McGuire C, Adams MD, Redline S (2010) A candidate gene study of obstructive sleep apnea in European Americans and African Americans. Am J Respir Crit Care Med 182:947–953
Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP (1997) Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 82:1313–1316
Kimoff RJ, Hamid Q, Divangahi M, Hussain S, Bao W, Naor N, Payne RJ, Ariyarajah A, Mulrain K, Petrof BJ (2011) Increased upper airway cytokines and oxidative stress in severe obstructive sleep apnoea. Eur Respir J 38:89–97
Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102:1369–1376
Zhang X, Liu RY, Lei Z, Zhu Y, Huang JA et al (2009) Genetic variants in interleukin-6 modified risk of obstructive sleep apnea syndrome. Int J Mol Med 23:485–493
Popko K, Gorska E, Potapinska O, Wasik M, Stoklosa A et al (2008) Frequency of distribution of inflammatory cytokines IL-1, IL-6 and TNF-alpha gene polymorphism in patients with obstructive sleep apnea. J Physiol Pharmacol 59(Suppl 6):607–614
Larkin EK, Patel SR, Zhu X, Tracy RP, Jenny NS et al (2010) Study of the relationship between the interleukin-6 gene and obstructive sleep apnea. Clin Transl Sci 3:337–339
Li TZ, Qian XS, Guo RB (2014) The relationship between the interleukin-6 gene and interleukin-10 gene polymorphism and obstructive sleep apnea with hypertension. Acad J Chin PLA Med School 35(3):276–279
Bielicki P, MacLeod AK, Douglas NJ, Riha RL (2015) Cytokine gene polymorphisms in obstructive sleep apnoea/hypopnoea syndrome. Sleep Med
Kaditis AG, Gozal D, Khalyfa A, Kheirandish-Gozal L, Capdevila OS et al (2014) Variants in C-reactive protein and IL-6 genes and susceptibility to obstructive sleep apnea in children: a candidate-gene association study in European American and Southeast European populations. Sleep Med 15:228–235
Roytblat L, Rachinsky M, Fisher A, Greemberg L, Shapira Y et al (2000) Raised interleukin-6 levels in obese patients. Obes Res 8:673–675
Liu H, Liu J, Xiong S, Shen G, Zhang Z et al (2000) The change of interleukin-6 and tumor necrosis factor in patients with obstructive sleep apnea syndrome. J Tongji Med Univ 20:200–202
Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H et al (2003) Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107:1129–1134
Alberti A, Sarchielli P, Gallinella E, Floridi A, Mazzotta G et al (2003) Plasma cytokine levels in patients with obstructive sleep apnea syndrome: a preliminary study. J Sleep Res 12:305–311
Ciftci TU, Kokturk O, Bukan N, Bilgihan A (2004) The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 28:87–91
Ryan S, Nolan GM, Hannigan E, Cunningham S, Taylor C et al (2007) Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax 62:509–514
Bravo Mde L, Serpero LD, Barcelo A, Barbe F, Agusti A et al (2007) Inflammatory proteins in patients with obstructive sleep apnea with and without daytime sleepiness. Sleep Breath 11:177–185
Harsch IA, Bergmann T, Koebnick C, Wiedmann R, Ruderich F et al (2007) Adiponectin, resistin and subclinical inflammation—the metabolic burden in Launois Bensaude Syndrome, a rare form of obesity. J Physiol Pharmacol 58(Suppl 1):65–76
Tomiyama H, Okazaki R, Inoue D, Ochiai H, Shiina K et al (2008) Link between obstructive sleep apnea and increased bone resorption in men. Osteoporos Int 19:1185–1192
Arias MA, Garcia-Rio F, Alonso-Fernandez A, Hernanz A, Hidalgo R et al (2008) CPAP decreases plasma levels of soluble tumour necrosis factor-alpha receptor 1 in obstructive sleep apnoea. Eur Respir J 32:1009–1015
Constantinidis J, Ereliadis S, Angouridakis N, Konstantinidis I, Vital V et al (2008) Cytokine changes after surgical treatment of obstructive sleep apnoea syndrome. Eur Arch Otorhinolaryngol 265:1275–1279
Takahashi K, Chin K, Nakamura H, Morita S, Sumi K et al (2008) Plasma thioredoxin, a novel oxidative stress marker, in patients with obstructive sleep apnea before and after nasal continuous positive airway pressure. Antioxid Redox Signal 10:715–726
Vgontzas AN, Zoumakis E, Bixler EO, Lin HM, Collins B et al (2008) Selective effects of CPAP on sleep apnoea-associated manifestations. Eur J Clin Invest 38:585–595
Yamamoto Y, Fujiuchi S, Hiramatsu M, Nishigaki Y, Takeda A et al (2008) Resistin is closely related to systemic inflammation in obstructive sleep apnea. Respiration 76:377–385
Li Y, Chongsuvivatwong V, Geater A, Liu A (2009) Exhaled breath condensate cytokine level as a diagnostic tool for obstructive sleep apnea syndrome. Sleep Med 10:95–103
Thomopoulos C, Tsioufis C, Dimitriadis K, Tsiachris D, Tousoulis D et al (2009) Obstructive sleep apnoea syndrome is associated with enhanced sub-clinical inflammation and asymmetric dimethyl-arginine levels in hypertensives. J Hum Hypertens 23:65–67
Steiropoulos P, Papanas N, Nena E, Antoniadou M, Serasli E et al (2010) Inflammatory markers in middle-aged obese subjects: does obstructive sleep apnea syndrome play a role? Mediators Inflamm 2010:675320
Sahlman J, Miettinen K, Peuhkurinen K, Seppa J, Peltonen M et al (2010) The activation of the inflammatory cytokines in overweight patients with mild obstructive sleep apnoea. J Sleep Res 19:341–348
Ye L, Ma GH, Chen L, Li M, Liu JL et al (2010) Quantification of circulating cell-free DNA in the serum of patients with obstructive sleep apnea-hypopnea syndrome. Lung 188:469–474
Medeiros CA, de Bruin VM, Andrade GM, Coutinho WM, de Castro-Silva C et al (2012) Obstructive sleep apnea and biomarkers of inflammation in ischemic stroke. Acta Neurol Scand 126:17–22
Fornadi K, Lindner A, Czira ME, Szentkiralyi A, Lazar AS et al (2012) Lack of association between objectively assessed sleep disorders and inflammatory markers among kidney transplant recipients. Int Urol Nephrol 44:607–617
Qian X, Yin T, Li T, Kang C, Guo R et al (2012) High levels of inflammation and insulin resistance in obstructive sleep apnea patients with hypertension. Inflammation 35:1507–1511
Kurt OK, Tosun M, Talay F (2013) Serum cardiotrophin-1 and IL-6 levels in patients with obstructive sleep apnea syndrome. Inflammation 36:1344–1347
Yang D, Liu Z, Luo Q (2013) Plasma ghrelin and pro-inflammatory markers in patients with obstructive sleep apnea and stable coronary heart disease. Med Sci Monit 19:251–256
Hargens TA, Guill SG, Kaleth AS, Nickols-Richardson SM, Miller LE et al (2013) Insulin resistance and adipose-derived hormones in young men with untreated obstructive sleep apnea. Sleep Breath 17:403–409
Kritikou I, Basta M, Vgontzas AN, Pejovic S, Liao D et al (2014) Sleep apnoea, sleepiness, inflammation and insulin resistance in middle-aged males and females. Eur Respir J 43:145–155
Unuvar Dogan F, Yosunkaya S, Kuzu Okur H, Can U (2014) Relationships between obstructive sleep apnea syndrome, continuous positive airway pressure treatment, and inflammatory cytokines. Sleep Disord 2014:518920
Ciccone MM, Scicchitano P, Zito A, Cortese F, Boninfante B et al (2014) Correlation between inflammatory markers of atherosclerosis and carotid intima-media thickness in obstructive sleep apnea. Molecules 19:1651–1662
Thunstrom E, Glantz H, Fu M, Yucel-Lindberg T, Petzold M et al (2015) Increased inflammatory activity in nonobese patients with coronary artery disease and obstructive sleep apnea. Sleep 38:463–471
Tam CS, Wong M, McBain R, Bailey S, Waters KA (2006) Inflammatory measures in children with obstructive sleep apnoea. J Paediatr Child Health 42:277–282
Gozal D, Serpero LD, Sans Capdevila O, Kheirandish-Gozal L (2008) Systemic inflammation in non-obese children with obstructive sleep apnea. Sleep Med 9:254–259
Li AM, Lam HS, Chan MH, So HK, Ng SK et al (2008) Inflammatory cytokines and childhood obstructive sleep apnoea. Ann Acad Med Singapore 37:649–654
Gileles-Hillel A, Alonso-Alvarez ML, Kheirandish-Gozal L, Peris E, Cordero-Guevara JA et al (2014) Inflammatory markers and obstructive sleep apnea in obese children: the NANOS study. Mediators Inflamm 2014:605280
Harsch IA, Koebnick C, Wallaschofski H, Schahin SP, Hahn EG et al (2004) Resistin levels in patients with obstructive sleep apnoea syndrome—the link to subclinical inflammation? Med Sci Monit 10:CR510–CR515
Burioka N, Miyata M, Fukuoka Y, Endo M, Shimizu E (2008) Day-night variations of serum interleukin-6 in patients with severe obstructive sleep apnea syndrome before and after continuous positive airway pressure (CPAP). Chronobiol Int 25:827–834
Dorkova Z, Petrasova D, Molcanyiova A, Popovnakova M, Tkacova R (2008) Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest 134:686–692
Li Y, Chongsuvivatwong V, Geater A, Liu A (2008) Are biomarker levels a good follow-up tool for evaluating obstructive sleep apnea syndrome treatments? Respiration 76:317–323
Carneiro G, Togeiro SM, Ribeiro-Filho FF, Truksinas E, Ribeiro AB et al (2009) Continuous positive airway pressure therapy improves hypoadiponectinemia in severe obese men with obstructive sleep apnea without changes in insulin resistance. Metab Syndr Relat Disord 7:537–542
Drummond M, Winck J, Guimaraes J, Santos AC, Almeida J et al (2009) Long term effect of autoadjusting positive airway pressure on C-reactive protein and interleukin-6 in men with obstructive sleep apnoea syndrome. Arch Bronconeumol 45:577–584
Oyama J, Yamamoto H, Maeda T, Ito A, Node K et al (2012) Continuous positive airway pressure therapy improves vascular dysfunction and decreases oxidative stress in patients with the metabolic syndrome and obstructive sleep apnea syndrome. Clin Cardiol 35:231–236
Karamanli H, Ozol D, Ugur KS, Yildirim Z, Armutcu F et al (2014) Influence of CPAP treatment on airway and systemic inflammation in OSAS patients. Sleep Breath 18:251–256
Lloberes P, Sanchez-Vidaurre S, Ferre A, Cruz MJ, Lorente J et al (2014) Effect of continuous positive airway pressure and upper airway surgery on exhaled breath condensate and serum biomarkers in patients with sleep apnea. Arch Bronconeumol 50:422–428
Stradling JR, Craig SE, Kohler M, Nicoll D, Ayers L et al (2015) Markers of inflammation: data from the MOSAIC randomised trial of CPAP for minimally symptomatic OSA. Thorax 70:181–182
Kelishadi R, Nilforoushan N, Okhovat A, Amra B, Poursafa P et al (2011) Effects of adenoidectomy on markers of endothelial function and inflammation in normal-weight and overweight prepubescent children with sleep apnea. J Res Med Sci 16(Suppl 1):S387–S394
Kheirandish-Gozal L, Gileles-Hillel A, Alonso-Alvarez ML, Peris E, Bhattacharjee R, et al. (2015) Effects of adenotonsillectomy on plasma inflammatory biomarkers in obese children with obstructive sleep apnea: A community-based study. Int J Obes (Lond)
Lijuan C, Qiuhong L (2013) The evaluation of adenotonsillectomy on TNF-a and IL-6 levels in obese children with obstructive sleep apnea. Int J Pediatr Otorhinolaryngol 77:690–694
Mutlu M, Vuralkan E, Yardim AS, Akin I, Miser E (2014) Effects of adenoid/tonsillectomy on inflammatory response in snoring children with witnessed apnoea. Clin Otolaryngol 39:266–271
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62:1006–1012
Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558
Zintzaras E, Ioannidis JP (2005) Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol 28:123–137
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
Zintzaras E, Kitsios G, Stefanidis I (2006) Endothelial NO synthase gene polymorphisms and hypertension: a meta-analysis. Hypertension 48:700–710
Zintzaras E, Stefanidis I, Santos M, Vidal F (2006) Do alcohol-metabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease? Hepatology 43:352–361
Hozo SP, Djulbegovic B, Hozo I (2015) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13
Ylmaz M, Bayazit YA, Ciftci TU, Erdal ME, Urhan M et al (2005) Association of serotonin transporter gene polymorphism with obstructive sleep apnea syndrome. Laryngoscope 115:832–836
Woods A, Brull DJ, Humphries SE, Montgomery HE (2000) Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur Heart J 21:1574–1583
Ryan S, Taylor CT, McNicholas WT (2005) Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112:2660–2667
Dempsey JA, Veasey SC, Morgan BJ, O’Donnell CP (2010) Pathophysiology of sleep apnea. Physiol Rev 90:47–112
Nadeem R, Molnar J, Madbouly EM, Nida M, Aggarwal S et al (2013) Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med 9:1003–1012
Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A et al (2000) Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 85:1151–1158
Xie X, Pan L, Ren D, Du C, Guo Y (2013) Effects of continuous positive airway pressure therapy on systemic inflammation in obstructive sleep apnea: a meta-analysis. Sleep Med 14:1139–1150
Baessler A, Nadeem R, Harvey M, Madbouly E, Younus A et al (2013) Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers—a meta-analysis. J Inflamm (Lond) 10:13
Tauman R, Gozal D (2011) Obstructive sleep apnea syndrome in children. Expert Rev Respir Med 5:425–440
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Additional information
Anyuan Zhong and Xiaolu Xiong contributed equally to this work.
Rights and permissions
About this article
Cite this article
Zhong, A., Xiong, X., Shi, M. et al. Roles of interleukin (IL)-6 gene polymorphisms, serum IL-6 levels, and treatment in obstructive sleep apnea: a meta-analysis. Sleep Breath 20, 719–731 (2016). https://doi.org/10.1007/s11325-015-1288-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11325-015-1288-6